6533b7d9fe1ef96bd126cd8d
RESEARCH PRODUCT
Polyphenol-rich and alcoholic beverages and metabolic status in adults living in Sicily, Southern Italy
Agnieszka MicekRaffaele Ivan CincioneMassimo LibraAchille CernigliaroSilvio BuscemiJustyna GodosFabio GalvanoGiuseppe Grossosubject
0301 basic medicinemedicine.medical_specialtyHealth (social science)teabeverageschlorogenic acidcoffeeContext (language use)Plant Science030204 cardiovascular system & hematologyhydroxycinnamic acidslcsh:Chemical technologyHealth Professions (miscellaneous)MicrobiologyjuiceArticle03 medical and health sciences0302 clinical medicineEnvironmental healthEpidemiologymedicineflavonoidlcsh:TP1-1185JUICE.Settore MED/49 - Scienze Tecniche Dietetiche Applicatewinepolyphenols030109 nutrition & dieteticsphenolic acidbusiness.industryConfoundingfood and beveragesOdds ratiomedicine.diseaseAlcoholic beverage consumptionpolyphenolWhite WineCohortflavonoidsbeerbusinessphenolic acidsDyslipidemiaFood Sciencedescription
Polyphenol-rich beverage consumption is not univocally accepted as a risk modulator for cardio-metabolic risk factors, despite mechanistic and epidemiological evidence suggesting otherwise. The aim of this study was to assess whether an association between polyphenol-rich beverage consumption and metabolic status could be observed in a Mediterranean cohort with relatively low intake of tea, coffee, red and white wine, beer, and fresh citrus juice. Demographic and dietary characteristics of 2044 adults living in southern Italy were analyzed. Multivariate logistic regression analyses were used to calculate odds ratios (ORs) and 95% confidence intervals (CIs) of the association between polyphenol-rich and alcoholic beverage consumption and metabolic status adjusted for potential confounding factors. Specific polyphenol-rich beverages were associated, to a various extent, with metabolic outcomes. Individuals with a higher total polyphenol-rich beverages had higher polyphenols intake and were less likely to have hypertension, type-2 diabetes, and dyslipidemia (OR = 0.57, 95% CI: 0.44–0.73
year | journal | country | edition | language |
---|---|---|---|---|
2021-02-01 |